当前位置: 首页 > 期刊 > 《医药产业资讯》 > 20208
编号:13496939
不同分子分型青年乳腺癌的临床特点及预后因素分析(4)
http://www.100md.com 2020年3月15日 《中国医药导报》 20208
     [19] Adriana-Andreea J,Maria CA,Domenico R,et al. Triple negative breast cancer:the kiss of death [J]. Oncotarget,2017,8(28):46652-46662.

    [20] Maishman T,Cutress RI,Hernandez A,et al. Local Recurrence and Breast Oncological Surgery in Young Women With Breast Cancer [J]. Ann Surg,2017,266(1):165-172.

    [21] 宋美英,王玲,张财家,等.对比分析青年及中老年乳腺癌患者临床病理特征及免疫组化特点[J].当代医学,2019,25(28):80-82.

    [22] Ellegaard MBB,Grau C,Zachariae R,et al. Fear of cancer recurrence and unmet needs among breast cancer survivors in the first five years. A cross-sectional study [J]. Acta Oncol,2017,56(2):314-320.

    [23] Liedtke C,Rody A,Gluz O,Baumann K,et al. The prognostic impact of age in different molecular subtypes of breast cancer [J]. Breast Cancer Res Treat,2015,152(3):667-673.

    [24] Gregorio DI,Ford C,Samociuk H. Geography of breast cancer incidence according to age & birth cohorts [J]. Spat Spatiotemporal Epidemiol,2017,21(3):47-55.

    [25] Wen D,Wen X,Yang Y,et al. Urban rural disparity in female breast cancer incidence rate in China and the increasing trend in parallel with socioeconomic development and urbanization in a rural setting [J]. Thorac Cancer,2018,9(2):262-272.

    [26] 韋玉亚,姜伟,朱婷,等.X线和彩色多普勒超声成像在早期乳腺癌诊断中的价值[J].中国医药科学,2019,9(13):160-163.

    (收稿日期:2019-07-02 本文编辑:封 华), http://www.100md.com(艾勇彪 袁杰 李文仿)
上一页1 2 3 4